Archive · 4 Sep 2025
Weight-Loss Drugs Reshape Diet and the Snack Shelf
Imagine some medicines that help people lose weight and control their blood sugar.
These medicines, like Mounjaro and Wegovy, make you feel less hungry, so you eat less.
One person, Aakash, lost a lot of weight, but he also had to change what he ate.
He ate healthier foods with more protein and fiber.
These medicines are helpful, but they can be expensive.
However, the price might drop soon.
This is because the patent for one of them is ending, which means other companies can make them cheaper.
Weight-loss drugs, like Mounjaro, cause significant weight loss and reduced appetite.
Patients must change their diet, increasing fiber and protein.
Aakash lost over 19 kg in six months using such drugs.
These drugs are becoming popular in India, with a large diabetic population.
Prices might drop significantly when patents expire.
- Who
- People using weight-loss drugs like Mounjaro, Wegovy, and Ozempic.
- What
- Weight-loss drugs are leading to drastic lifestyle shifts.
- When
- The lifestyle shifts are occurring now.
- Where
- India, where there's a large diabetic population.
- Why
- To lose weight and manage diabetes.
- Drug Class
- GLP-1 (glucagon-like peptide-1)
- Common Drugs
- Mounjaro, Wegovy, Ozempic
- Primary Effect
- Weight Loss, Diabetes Management
- Patient Experience
- Reduced Appetite, Nausea if overeating
- Lifestyle Shift
- Improved diet and portion control required
- Anticipated Price Drop
- Over 80% (Wegovy/Ozempic off-patent)